106 related articles for article (PubMed ID: 12894225)
1. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
Hayes SA; Huang X; Kambhampati S; Platanias LC; Bergan RC
Oncogene; 2003 Jul; 22(31):4841-50. PubMed ID: 12894225
[TBL] [Abstract][Full Text] [Related]
2. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
4. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.
Fu Y; O'Connor LM; Shepherd TG; Nachtigal MW
Biochem Biophys Res Commun; 2003 Oct; 310(2):391-7. PubMed ID: 14521923
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
Buck MB; Pfizenmaier K; Knabbe C
Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
[TBL] [Abstract][Full Text] [Related]
7. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.
Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS
Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways.
Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF
J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024
[TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
10. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
[TBL] [Abstract][Full Text] [Related]
11. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
[TBL] [Abstract][Full Text] [Related]
12. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.
Kamaraju AK; Roberts AB
J Biol Chem; 2005 Jan; 280(2):1024-36. PubMed ID: 15520018
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest.
Smalley KS; Eisen TG
Melanoma Res; 2002 Jun; 12(3):187-92. PubMed ID: 12140374
[TBL] [Abstract][Full Text] [Related]
14. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
16. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium.
Saika S; Okada Y; Miyamoto T; Yamanaka O; Ohnishi Y; Ooshima A; Liu CY; Weng D; Kao WW
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):100-9. PubMed ID: 14691160
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
19. Rapid signalling by androgen receptor in prostate cancer cells.
Peterziel H; Mink S; Schonert A; Becker M; Klocker H; Cato AC
Oncogene; 1999 Nov; 18(46):6322-9. PubMed ID: 10597231
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells.
Selvamurugan N; Fung Z; Partridge NC
FEBS Lett; 2002 Dec; 532(1-2):31-5. PubMed ID: 12459458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
